Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

ICV administration of CRF blocker (CRF(9-41 δ) helical) reduces morphine withdrawal in rats

  • Sara Brugger
  • , Rosa Sanchez
  • , Arturo J. Brugger
  • , Jose Antonio Martinez*
  • *Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

13 Citas (Scopus)

Resumen

1. The effects of CRF(9-41 δ) helical on morphine withdrawal signs in rats were studied 2. Intracerebroventricular administration of CRF(9-41 δ) helical 5 at 10 μg/kg reduced central and peripheral symptons of the withdrawal syndrome, such as ptosis, jumping, wet dog shakes and teeth chatering; other signs remained unchanged. The effect were not dose dependent. 3. The hypothermi characteristic of the Withdrawal syndrome was reduced by CRF(9-41 δ) helical. 4. These results suggest that the hypothalamo pituitary adrenal(HPA) axis play an important role in the morphine withdrawal syndrome in rats.

Idioma originalInglés
Páginas (desde-hasta)775-785
Número de páginas11
PublicaciónProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volumen22
N.º5
DOI
EstadoPublicada - jul 1998
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'ICV administration of CRF blocker (CRF(9-41 δ) helical) reduces morphine withdrawal in rats'. En conjunto forman una huella única.

Citar esto